Tuesday 19th April 2022 |
Text too small? |
WELLINGTON New Zealand – Chatham Rock Phosphate Limited (TSXV: “NZP” and NZX: “CRP” or the “Company") is pleased to announce, further to the Company’s news release concerning this acquisition dated October 14, 2021, that the Australian Foreign Investment Review Board (FIRB) has just approved the acquisition by CRP’s wholly owned subsidiary Korella Mining Pty Ltd of the Korella Mining Tenement ML90209
FIRB approval, a condition precedent of the acquisition, was required because the Company is predominantly owned by shareholders not domiciled in Australia.
This paves the way forward to a speedy conclusion of the acquisition of the Korella mine from Australia Venus Resources and to the required TSXV approval of the $A2 million share issue relating to the transaction.
In anticipation of the FIRB approval and the completion of the acquisition Chatham’s executive director Colin Randall and recently appointed Field Services Manager Maurice March have already established a base in Cloncurry, the nearest town. They have already made significant progress towards the joint aims of expediting the immediate sale of an already mined stockpile, future transport arrangements and commencing mining operations from the existing open pit.
During the last two months we have identified a preferred site for the grinding, bagging and dispatch of Korella rock phosphate. We have also commenced negotiations with mining contractors, transport and processing plant providers and been actively involved with key local stakeholders, including the landowner and the local government authorities.
On the marketing front we have established the Korella phosphate rock specification, together with a pricing schedule for rock delivered ex-works at Cloncurry. We have identified a very wide range of potential customers and have been contacting them.
Subject to access to the mine site, following the acquisition, and arrangements for crushing and bagging in Cloncurry, the first sales of Korella phosphate are now expected in July.
The start of cash generation from phosphate sales will mark a transformative milestone for the Company.
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b